Evidence map›Paper›PMID 27618646›Full record

ReviewThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2016

The Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging.

Patrick J Brown, Bret R Rutherford, Kristine Yaffe, Jane M Tandler, Justina Laurence Ray, Emily Pott, Sarah Chung, Steven P Roose

Abstract readReview
In one paragraph

Review in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Bidirectional causal association between frailty and six psychiatric disorders.European archives of psychiatry and clinical neuroscience · 2026
    Article
  11. Frailty and [Theranostics · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Patrick J BrownCollege of Physicians and Surgeons, Columbia University, New York, NY; New York State Psychiatric Institute, New York, NY. Electronic address: pb2410@cumc.columbia.edu.
Bret R RutherfordCollege of Physicians and Surgeons, Columbia University, New York, NY; New York State Psychiatric Institute, New York, NY.
Kristine YaffeDepartments of Neurology, Psychiatry, Epidemiology, and Biostatistics, University of California, San Francisco, CA.
Jane M TandlerNew York State Psychiatric Institute, New York, NY.
Justina Laurence RayNew York State Psychiatric Institute, New York, NY.
Emily PottNew York State Psychiatric Institute, New York, NY.
Sarah ChungNew York State Psychiatric Institute, New York, NY.
Steven P RooseCollege of Physicians and Surgeons, Columbia University, New York, NY; New York State Psychiatric Institute, New York, NY.

Funding

Research Training in Late-Life NeuroPsychiatric DisordersT32MH020004 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Patrick J Brown · 1998 to 2026
$6.1M
The Phenomenology and Antidepressant Treatment of Depressed, Frail Older AdultsK23MH099097 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BROWN, PATRICK J · 2013 to 2017
$850k
NIMH NIH HHS K23 MH099097NIMH NIH HHS T32 MH020004
6 · The paper itself

Abstract

Depression in later life is a severe public health problem, associated with higher rates of mortality, suicide, and dementia. Effectiveness of treatment is limited by the failure to deconstruct the heterogeneity of the illness and because diagnostic criteria, pathophysiological models, and treatment algorithms for depression are primarily based on studies of younger adults even though symptoms of the illness and physiology of the patient change with age. Thus, understanding how aging interacts with depressive illness may elucidate endophenotypes of late-life depression with different clinical manifestations and underlying mechanisms that can then be targeted with more personalized approaches to treatment. This paper proposes a model for the critical confluence between depression and frailty, a high-risk morbidity and mortality syndrome of later life. This model hypothesizes that characteristics of frailty in adults with late life depression represent the clinical manifestation of greater biological aging and their presence in the context of a depressive illness exposes elders to deleterious trajectories. Potential common biological substrates that may result in the manifestation of the depressed frail phenotype including mitochondrial functioning, dopaminergic neurotransmission, and inflammatory processes and implications for the assessment and treatment of adults with late-life depression are discussed. As society continues to live longer, the preservation of the quality of these added years becomes paramount, and the combined impact of depression and frailty on the preservation of this quality warrants the attention of clinical researchers and physicians.

Indexed as

AgingDepressive DisorderDopamineFrailtyHumansInflammationMitochondriaOxidative StressPhenotypeSynaptic TransmissionDopamineDepressiondopaminefrailtyinflammationmitochondria

Identifiers

PMID27618646
PMCPMC5069140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.